Exane Derivatives’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-1,013
| Closed | -$101K | – | 686 |
|
|
2019
Q3 | $101K | Hold |
1,013
| – | – | 0.02% | 306 |
|
|
2019
Q2 | $93.6K | Sell |
1,013
-653
| -39% | -$60.3K | 0.02% | 323 |
|
|
2019
Q1 | $157K | Sell |
1,666
-988
| -37% | -$93.2K | 0.03% | 238 |
|
|
2018
Q4 | $170K | Buy |
2,654
+2,600
| +4,815% | +$167K | 0.03% | 240 |
|
|
2018
Q3 | $4.83K | Sell |
54
-752
| -93% | -$67.3K | ﹤0.01% | 429 |
|
|
2018
Q2 | $64.6K | Sell |
806
-3,624
| -82% | -$291K | 0.01% | 342 |
|
|
2018
Q1 | $390K | Buy |
4,430
+2,464
| +125% | +$217K | 0.08% | 165 |
|
|
2017
Q4 | $205K | Buy |
1,966
+1,247
| +173% | +$130K | 0.04% | 216 |
|
|
2017
Q3 | $105K | Sell |
719
-117
| -14% | -$17.1K | 0.02% | 228 |
|
|
2017
Q2 | $109K | Sell |
836
-127
| -13% | -$16.5K | 0.02% | 237 |
|
|
2017
Q1 | $120K | Sell |
963
-828
| -46% | -$103K | 0.03% | 202 |
|
|
2016
Q4 | $207K | Sell |
1,791
-207
| -10% | -$24K | 0.04% | 178 |
|
|
2016
Q3 | $209K | Buy |
+1,998
| New | +$209K | 0.03% | 185 |
|
|
2016
Q2 | – | Sell |
-2,633
| Closed | -$264K | – | 606 |
|
|
2016
Q1 | $264K | Buy |
2,633
+114
| +5% | +$11.4K | 0.04% | 156 |
|
|
2015
Q4 | $302K | Buy |
2,519
+502
| +25% | +$60.1K | 0.04% | 122 |
|
|
2015
Q3 | $218K | Buy |
2,017
+771
| +62% | +$83.4K | 0.03% | 160 |
|
|
2015
Q2 | $144K | Buy |
+1,246
| New | +$144K | 0.02% | 202 |
|
|
2015
Q1 | – | Sell |
-52
| Closed | -$5.82K | – | 524 |
|
|
2014
Q4 | $5.82K | Buy |
+52
| New | +$5.82K | ﹤0.01% | 378 |
|